Skip to content

A retrospective analysis of the obliteration rate after stereotactic radiotherapy using different radiation dose schedules in intracranial arteriovenous malformation

A retrospective analysis of the obliteration rate after stereotactic radiotherapy using different radiation dose schedules in intracranial arteriovenous malformation

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
TCTR
Registry ID
TCTR20240608005
Enrollment
100
Registered
2024-06-08
Start date
2023-09-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Brain Arteriovenous Malformation that used Hypofractionated radiation method for treatment. Arteriovenous Malformation, Intracranial Intracranial Arteriovenous Malformation Malformation, Intracranial Arteriovenous Malformations, Intracranial Arteriovenous AVM (Arteriovenous Malformation) Intracranial Congenital Intracranial Arteriovenous Malformations Intracranial Arteriovenous Malformations, Congenital Arteriovenous Malformations, Cerebral Cerebral Arteriovenous Malformation Malformation, Cere

Interventions

They received Stereotactic radiotherap schedule 30-36 Gy in 5-6 fractions. After finishing the SRT, They were going to attaining the follow up with their clinical and imaging every 3, months until the
Treatment,Treatment
SRT dose 30-36 Gy in 5-6 fx.,SRT 28Gy in 4 fx

Sponsors

Department of Radiology, Faculty of Medicine Chiang Mai University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients who underwent SRT during 2014 to 2021, 2. Patients who had a complete medical record and imaging investigations both before and after SRT were enrolled for analysis, 3. patients who received a 30-36 Gy regimen or a 28 Gy regimen.

Exclusion criteria

Exclusion criteria: 1.Patients who have Incomplete SRT dose, 2. Patients who lost of follow up, 3.Patients who have Incomplete Imaging investigation.

Design outcomes

Primary

MeasureTime frame
obliteration rate at 3 years 3 years after receiving SRT obliteration rate

Secondary

MeasureTime frame
median time to obliteration since patients receive SRT until the follow up imaging shows no AVM left Time in month, count since patients receive SRT until the follow up imaging shows no AVM left

Countries

Thailand

Contacts

Public ContactBongkot Jia Mahasap

Faculty of Medicine Chiang Mai University

phung_nemo@hotmail.com053935450

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026